Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004517715 | SCV005028932 | uncertain significance | not specified | 2023-11-23 | criteria provided, single submitter | clinical testing | The p.V304D variant (also known as c.911T>A), located in coding exon 4 of the GALNT12 gene, results from a T to A substitution at nucleotide position 911. The valine at codon 304 is replaced by aspartic acid, an amino acid with highly dissimilar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |